Parr McKnight Wealth Management Group’s AstraZeneca AZN Stock Holding History

Parr McKnight Wealth Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.87M	Buy	20,406 +1,401	+7%	+$264K	0.46%	69
2026 Q1	$3.75M	Buy	19,005 +2,320	+14%	+$447K	0.49%	62
2025 Q4	$3.07M	Sell	16,685 -300	-2%	-$52.6K	0.4%	83
2025 Q3	$2.61M	Buy	16,985 +355	+2%	+$53.7K	0.34%	94
2025 Q2	$2.32M	Buy	16,630 +1,052	+7%	+$147K	0.32%	103
2025 Q1	$2.29M	Buy	15,578 +2,554	+20%	+$370K	0.33%	105
2024 Q4	$1.71M	Buy	+13,024	New	+$1.82M	0.24%	106

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Parr McKnight Wealth Management Group's AZN Position: Q2 2026 in Review

Parr McKnight Wealth Management Group increased its AstraZeneca (AZN) stake by 7.4% in Q2 2026, buying an estimated $264K and bringing the position to 20,406 shares worth $3.87M. The position accounts for 0.46% of the portfolio, ranked #69.

Parr McKnight Wealth Management Group first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Parr McKnight Wealth Management Group held 20,406 shares of AstraZeneca worth $3.87M as of Q2 2026.
Parr McKnight Wealth Management Group bought 1,401 AstraZeneca shares in Q2 2026, an estimated $264K.
AstraZeneca made up 0.46% of Parr McKnight Wealth Management Group's portfolio in Q2 2026, its #69 holding.
Parr McKnight Wealth Management Group first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Parr McKnight Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.